|
Thursday
|
14th April
|
Friday
|
15th
April
|
Saturday
|
16th
April
|
|
7.30-8.30
|
REGISTRATION |
08.30-09.40
|
RADIOTHERAPY
Chair:R.Orecchia,
IT-H.Basic,BA
|
09.00
-11.45
|
BREAST
CANCER GUIDELINES - ARE THEY ALL THE SAME?
Chair and
discussion co-ordinstor: tbc
|
|
08.30-09.10
|
EPIDEMILOGY
AND PREVENTION
Chair:
M.Primic-Zakelj,Sl
|
08.30
|
Imaging
for breast cancer radiotherapy planning
H.Basic,BA
|
9.00
|
St.
Gallen Consensus 2005 |
|
08.30
|
Epidemiology
- incidences ...
M.Primec-Zakelj, Sl. |
08.50 |
Adjuvant
radiotherapy in breast cancer
L. Atahan,TR
|
10.00
|
Discussion |
|
08.50
|
Does screening
save lives...
J.Zgajnar,SL
|
9.10
|
Partial
breast irradiation-where are we now?
R.Orecchia,IT
|
10.15
|
Coffee
break |
|
09.10
|
Discussion |
9.30
|
Discussion
|
10.45-11.45 |
HOW
TO MAKE THE BEST USE OF LIMITED RESOURCES
Chair:N.Obralić,BA-G.Kecman,BA |
|
09.20-11.00
|
DIAGNOSTICS
Chair:
F.Dalagija, BA - V.Malamou-Mitsi, GR
|
9.40
|
Coffee
break
|
10.45 |
Regional
countries' experience
N.Obralić,BA-G.Kecman,BA-E.Vrdoljak,HR-N.Borojević,CS
-P.Stefanovski,MK-S.Boulos,EG |
|
09.20
|
Mammography
and new imaging digital techniques-impact on questionable cases
S. Ciatto, IT |
10.00-11.20
|
ADJUVANT
AND NEOADJUVANT SYSTEMIC THERAPY
Chair:R.Jakesz,
AT-G.Kecman,
BA-N.Pavlidis,GR
|
11.45
|
Closing
remarks |
|
09.40
|
Ultrasound
and breast cancer-current status and future trends
M.Klancevic,BA
|
10.00 |
Neoadjuvant
systemic therapy
N.Pavlidis,GR
|
|
|
|
10.00
|
The
pathologist's role in therapy decision making
V.Malamo-Mitsi, GR
|
10.20 |
Adjuvant
themoterapy-texanes.Dose dense regimens
S.Bešlija
|
|
|
|
10.20
|
Prognostic
and predictive tissuer and molecular markers
N.Bilalovoć, BA
|
10.40 |
Optimisation
of endocrine treatment for premenopausal patients
R.Jakesz, AT
|
|
|
|
10.40
|
Discussion |
11.00 |
Are we
ready for aromatase inhibitors in adjuvant setting?
E.Vrdoljak, HR
|
|
|
|
11.00
|
Coffee
break |
11.20 |
Case
study discussion |
|
|
|
11.30
|
LIVE BREAST
CANCER SURGERY
A.Costa, IT
|
11.45-14.00 |
ADVANCED
AND DISSEMINATED DISEASE
Chair:S.Besilija,BA-T.Cufer,
Sl
|
|
|
|
13.30
|
Lunch |
11.45 |
Cheotherapy
in mmetasatic breast cancer
D.Vrbanec,
HR
|
|
|
|
15.00-16.50
|
EARLY
BREAST CANCER SURGERY
Chair:U. Veronesi; IT-O.Durić, BA |
12.00
|
New targets
for breast cancer therapy
Speaker to be confirmed
|
|
|
|
15.00
|
Breast
conserving surgery-overview and future perspectives
U.Veresoni,
IT
|
|
Bisphosphonates
in breast cancer-from bone metasteses treatment to the prevention
of bone loss
H.Basic, BA
|
|
|
|
15.45
|
Sentinel
node biopsy-from clinical trials to practice
J.Zgajnar,
SI
|
12.55
|
Palliative
and supportive care
T.Cufer, SI
|
|
|
|
16.15
|
Reconstructive
surgery
R.Dzodic,
CS
|
13.25
|
Case
study discussion
|
|
|
|
16.35
|
Discussion |
14.00
|
Lunch
|
|
|
|
|
Coffee
break |
15.30-17.00
|
PATIENTS'
RIGHTS
Chair: K. Redmond, ITS |
|
|
|
17.20-17.50
|
CARCINOMA
IN SITU
Moderaton:
V.Distante, IT
|
15.30
|
Life
with cancer-women against breast cancer(with participation of breast
cancer patients)
J.Dizdarević,BA
|
|
|
|
17.20
|
General
strategy-multidiscplinary approach
V.Distante, IT
|
16.00
|
Advocacy
rights for patients
K.Redmond, IT |
|
|
|
17.50
|
Panel dissusion
with presentation of clinical cases
N.Borojević,CS-A.Costa,IT-V.Malamou-Mitsi,GR-V.Distante, IT
|
16.30
|
The
impact of breast cancer on the family:the advocate's point of view
Europa Donna representative
|
|
|
|
|
|
17.00
|
Discussion
|
|
|
